SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Recent advances in non-pharmacological interventions for symptom burden management in breast cancer patients treated with ovarian function suppression.
Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveOvarian function suppression (OFS) treatment causes a sudden drop in patients' estrogen to postmenopausal levels, accompanied by associated side effects that are often abrupt and intense. This study aimed to provide an evidence base for clinical practice by systematically searching for the best current evidence on managing symptom burden in OFS-treated breast cancer patients.
methodWe systematically searched relevant evidence from the creation date to 21 November 2023 in computerized decision systems, guideline networks, professional society networks, and databases. The literature type included guidelines, expert consensus, systematic review, meta-analysis, recommended practice, best practice, clinical decision-making, and evidence summary. After three researchers independently screened and evaluated the literature, two researchers integrated the evidence and checked it by a third person.
resultsA total of 15 articles were selected, including six guidelines and nine expert consensus articles, and the overall literature quality was high. Thirty-eight pieces of evidence were summarized into eight areas: supportive elements of symptom burden management, health education, regular assessment and monitoring, diet and nutrition, exercise training, lifestyle, prevention and control of comorbidities, and complementary and alternative therapies.
conclusionThis study summarizes the best evidence on non-pharmacological interventions for symptom burden management in OFS-treated breast cancer patients, guiding clinical practice. As non-pharmacological interventions for symptom burden management in OFS-treated breast cancer patients are still in their infancy, the best evidence for OFS-treated breast cancer patients should be selected for clinical application in the future in a site-specific and individualized manner, and the best evidence should be continuously updated.
Indexed as
Identifiers
41680554What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.